Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia

Ann Hematol. 2016 Jun;95(7):1197-200. doi: 10.1007/s00277-016-2664-4. Epub 2016 Apr 11.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Humans
  • Leukemia, Neutrophilic, Chronic / drug therapy*
  • Leukemia, Neutrophilic, Chronic / genetics*
  • Male
  • Mutation / genetics*
  • Pyrazoles / therapeutic use*
  • Receptors, Colony-Stimulating Factor / genetics*
  • Treatment Outcome

Substances

  • CSF3R protein, human
  • INCB018424
  • Pyrazoles
  • Receptors, Colony-Stimulating Factor